Aromatase Inhibitors May Benefit Premenopausal Women With Breast Cancer
For premenopausal women receiving ovarian suppression, risk for breast cancer recurrence reduced with aromatase inhibitor versus tamoxifen
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Tamoxifen | Women